The biological basis of aging (also known as senescence) is the subject of debate. A number of theories suggest aging is inevitable, the product of “wear and tear” or a result of some evolutionary necessity. For example, Skulachev argues that aging performs a specific biological function, with the turnover in new members of a species promoting greater evolutionary fitness.1 One of the longstanding problems of such theories is that they fail to account for dramatically different lifespans, or for the fact that chronic diseases are identical in presentation to diseases of the aging.
According to the Marshall Pathogenesis, chronic microbes drive the aging process, in light of the fact that diseases and symptoms of aging are at their essence, inflammatory conditions. It is the damage done by microbes coupled with the body's response to these pathogens which is responsible for aging skin, wrinkles, and the wear and tear on organs.
A number of unsatisfactory theories have been touted to explain why aging occurs:
Moody writes, “Normal aging can be defined as an underlying time-dependent biological process that, although not itself a disease, involves functional loss and susceptibility to disease and death.2 Is aging inevitable?
There are two key problems with most conventional theories of aging. There is simply too much variability in symptoms of aging. The dramatic discrepancy lifespans suggests it's more than just chance which causes the symptoms of senescence.
For example, consider an 18-year old male who has constipation, brain fog, and insomnia. Omit his age, and on paper, he sounds like an 80-year old. How are his symptoms qualitatively any different than his 80-year old counterpart's?
According to the Marshall Pathogenesis, diseases of the aging are simply late onset chronic diseases caused by infection.
Aging is a super-category. We’ve gradually lumped together more and more symptoms under the category of natural aging. Many of these symptoms are the same as those caused by diseases that surely have an infectious cause. In that sense, you could view much of what we now call aging as an incapacitating illness that leads to a decrease in function. We know that inflammation and the interaction of the immune system with pathogens can destroy tissue. So it’s not surprising that the tissues of a person who harbors a lot of pathogens would age earlier and alter their biological structure earlier in life. I do believe it is inevitable that people will eventually die of old age, but I suspect that this should generally happen when they are 80-100 years old. But we are increasingly seeing signs of aging-related diseases in people who are much younger.
Paul Ewald, Bacteriality interview
A typical feature of aging is a chronic, low-grade inflammation characterized by a general increase in the production of pro-inflammatory cytokines and inflammatory markers.3 There is even a term for it: inflammaging. According to Franchesci: “A large part of the aging phenotype, including immunosenescence, is explained by an imbalance between inflammatory and anti-inflammatory networks, which results in the low grade chronic pro-inflammatory status we proposed to call inflammaging.”4
Could the chronic inflammation associated with aging be caused by pathogens? Given the crudeness of tools now used to measure microbes and the ubiquity of the human microbiota, this seems like a reasonable if not inevitable conclusion as the early studies have begun to suggest.
At present, a study on gut microbiota composition shows that three main modifications occur in faecal microbiota from old frail subjects: a 26-fold reduction in the number of lactobacilli (which stimulate immune functions and help the nutrient absorption), a 3-fold reduction in the number of bacteriodes (which digest polysaccarides, some species are opportunist pathogens) and a 7-fold increase in the number of enterobacteriacee (potentially pathogens)9. Differences in faecal microbiota were also found in a study on people of different countries and ages, including aged and long-lived people10.
The VDR plays a plays a crucial, often under-appreciated, role in the innate immune response. Further underscoring the potential role of microbes in chronic disease, there are several demonstrated connections between VDR dysfunction and premature aging.
Overall, VDR KO mice showed several aging related phenotypes, including poorer survival, early alopecia, thickened skin, enlarged sebaceous glands and development of epidermal cysts…. Unlike the wildtype controls, VDR KO mice lose their ability to swim after 6 months of age. Expression of all the genes was lower in old VDR KO mice, but only NF-kappaB, Fgf-23, p53 and IGF1R were significantly lower. Since the phenotype of aged VDR knockout mice is similar to mouse models with hypervitaminosis D(3), our study suggests that VDR genetic ablation promotes premature aging in mice, and that vitamin D(3) homeostasis regulates physiological aging.
T. Keisala et al.15
Hair graying, also known as achromotrichia, is the most obvious sign of aging in humans. Change in hair color occurs when melanin ceases to be produced in the hair root and new hairs grow in without pigment. The stem cells at the base of hair follicles produce melanocytes, the cells that produce and store pigment in hair and skin. The death of the melanocyte stem cells causes the onset of graying.18
For most researchers at least, the mechanisms which ultimately drive the process are largely unknown,19 However, there is reason to believe that the decline in melanin production by melanocyte stem cells may be due to an inflammatory process driven by the Th1 pathogens.
One important factor in understanding why hair turns gray may prove to be activity to the Vitamin D Receptor (VDR), a receptor which is responsible for mounting an immune response to pathogenic bacteria. One of the many genes the Receptor transcribes is for hair follicles.
VDR expression in the epidermal component of the hair follicle, the keratinocyte, is critical for maintenance of the hair cycle.
Kristi Skorija, et al. 20
===== Symptoms ===== ===== Management ===== ===== Other treatments ===== ===== Tests ===== ===== Diagnosis ===== ===== Epidemiology ===== ===== Types ===== ===== Evidence of infectious cause===== ===== Role of vitamin D metabolism ===== ===== Politics ===== ===== Patient interviews ===== ===== Presentations and publications=====
APMIS. 2012 Oct;120(10):773-7. doi: 10.1111/j.1600-0463.2012.02899.x. Epub 2012 Mar 23. Age-related prevalence of Methanomassiliicoccus luminyensis in the human gut microbiome.
Dridi B, Henry M, Richet H, Raoult D, Drancourt M. Source
Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, IHU Méditerranée Infection, Aix-Marseille- Université, Marseille, France.
A 16S rDNA sequence-based investigation of methanogenic Archaea in the human stools found Methanobrevibacter smithii in 99.2% and Methanosphaera stadtmanae in 32.6%. The recently described Methanomassiliicoccus luminyensis found by others to be representative of a new order of methanogenic Archaea was found in 4% of stool specimens. The prevalence of M. luminyensis significantly increased with age, contrary to M. smithii and M. stadtmanae.
© 2012 The Authors APMIS © 2012 APMIS.
Inflammatory and Immunological parameters in adults with Down syndrome Maria BF Trotta1*, João B Serro Azul1, Mauricio Wajngarten1, Simone G Fonseca1, Anna C Goldberg2 and Jorge E Kalil1 RESEARCH Open Access Abstract Background: The increase in life expectancy within the general population has resulted in an increasing number of elderly adults, including patients with Down syndrome (DS), with a current life expectancy of about 50 years. We evaluate the parameters of humoral and cellular immune response, the quantitative expression of the regulator of calcineurin1 gene (RCAN1) and the production of cytokines. The study group consisted of adults DS (n = 24) and a control group with intellectual disability without Down syndrome (ID) (n = 21) and living in a similar environmental background. It was evaluated serology, immunophenotyping, the quantitative gene expression of RCAN1 and the production of cytokines. Results: In the DS group, the results showed an increase in NK cells, CD8, decreased CD19 (p < 0.05) and an increase spontaneous production of IFNgamma, TNFalpha and IL-10 (p < 0.05). There was not any difference in RCAN1 gene expression between the groups. Conclusions: These data suggest a similar humoral response in the two groups. The immunophenotyping suggests sign of premature aging of the immune system and the cytokine production show a proinflammatory profile.
As far as I can see, Th1 pathogens start to dictate the 'health' of just about everyone as they age. If you draw a graph of 25-D levels vs age, they drop steadily after age 40. Something is happening, even during 'healthy aging', that we really ought to understand a little more :)
There is a branch of medicine which is starting to look at Immunity and Aging. Here is a short letter I recently wrote to the editor of one of the journals: http://www.immunityageing.com/content/3/1/12/comments
Trevor Marshall, PhD
Aging, the accumulation of changes in an organism or object over time,
Cawthorn et al examined the telomeres of 143 people over the age of 60.21 Telomeres are DNA sequences on the ends of chromosomes that are gradually lost as cells replicate. The team found that those with shorter telomeres in blood DNA had significantly poorer survival, attributable in part to a 3.18-fold higher mortality rate from heart disease and, tellingly, a 8.54-fold higher mortality rate from infectious disease.
A number of the sickest patients on the Marshall Protocol, who are killing intracellular bacteria at the fastest rate possible, take over three years to completely recover their health. This hints at the large amount of pathogen-altered DNA that many people, even those who are not yet displaying the hallmarks of Th1 disease, are carrying.
Study shows that most older adults have signs of brain damage http://bacteriality.com/2008/01/04/brain/
People who haven’t completed the MP consider it inevitable that as they age, they will need to stock up on any number of medications including thyroid medications, cardiac meds, statins, NSAIDS, B/P meds, etc. But people who have reached the later stages of the MP see no reason why they cannot take their level of healing to a maximum – to a point where they will never need these medications and may experience great health during their elder years.
EMBO Mol Med. 2010 Jul;2(7):247-57. Angiotensin II revisited: new roles in inflammation, immunology and aging. Benigni A, Cassis P, Remuzzi G. Mario Negri Institute for Pharmacological Research, Bergamo, Italy. Abstract That the renin-angiotensin system (RAS) is involved in regulation of blood pressure, vasoconstriction, sodium intake and potassium excretion is well established. Studies in the last few years have however documented new roles for this molecule as a pro-inflammatory molecule and more recently as a possible pro-fibrotic agent that contributes to progressive deterioration of organ function in disease. Binding of Ang II to its receptors (in particular AT(1)) mediates intracellular free radical generation that contributes to tissue damage by promoting mitochondrial dysfunction. Blocking Ang II signalling protects against neurodegenerative processes and promotes longevity in rodents. Altogether these findings open the unanticipated perspective for exploring Ang II signalling in therapeutic interventions in inflammatory diseases and aging-related tissue injury. This review extends from the discovery of Ang II and its implications in renal and cardiovascular physiology to cover the roles of the system in inflammation, tissue injury, autoimmunity, oxidative stress and aging.
It is evident in the decline in immune function that comes with aging.
That most of the researchers at the Conference stand on the edge of better understanding their results in the context of the Th1 pathogens was best exemplified by a presentation given by Rita Effros of UCLA. Effros actually presented data showing that chronic viral infection leads to an increase in senescent cells as well as significant decreases in telomere length. Effros stressed how the constant effort that the body must extend in order to try to keep latent viral infections under control clearly detracts from the energy the body needs in order to effectively manage the waste products that damage the tissues. Yet Effros is convinced that chronic viral infections cannot be eliminated and that, once present in a host, they cannot be stopped from causing an inflammatory response for the remainder of a patient’s life.
As Judith Campisi of the Lawrence Berkeley National Library and Buck Institute made clear in a speech, cancerous stimuli often foster the development of senescent cells and, as discussed above, the Th1 pathogens are quite prolific during cancer. But the greatest giveaway that senescent cells are at the mercy of the Th1 pathogens stems from the fact that, as Campisi described, senescent cells are metabolically active and secrete myriad inflammatory cytokines. In my opinion, nothing screams infection more than the release of inflammatory cytokines, since the inflammatory molecules are released by the immune system in response to infection. Campisi also described how, although senescent cells are targeted for clearance by the innate immune system, they are able to defy the immune response by secreting high levels of enzymes called matrix metalloproteinases (MMPs). In my opinion, the creation of these enzymes probably marks yet another way the Th1 pathogens have evolved to alter cellular machinery in order to foster their survival.
Hypothesis: The Aging Paradox and Autoimmune Disease22 Authors: Eyal Talora; Noel R. Rosea
Abstract The demographic imperatives of the 1990s and the coming decades point to a growing need for research on aging. Investigations of the mechanisms underlying age-related decrease in host defenses have been the focus of many clinical studies on immune function of the elderly1-3. Moreover, it is now estimated that 5% of the elderly population suffer from some form of autoimmune disease contributing to increased morbidity and, at times. to increased mortality in the aged population4-10 and that 10-15% of seemingly healthy individuals over the age of 60 have a significant level of autoantibodies in their serum11,12. The incidence of autoimmunity tends to increase in the aged population as compared with race- and sex-matched young adults4,11,12. Some immunological explanations of this phenomenon may include (i) a repeated or prolonged insult by endogenous auto-antigen, or (ii) molecular mimicry with environmental antigens, or (iii) decrease in the generation of suppressor cells.
Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. by Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, Rizzo C, Colonna-Romano G, Lio D, Di Carlo D, Palmas MG, Scurti M, Pini E, Franceschi C, Vasto S Related Articles Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches.
Curr Pharm Des. 2010;16(6):609-18
Authors: Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, Rizzo C, Colonna-Romano G, Lio D, Di Carlo D, Palmas MG, Scurti M, Pini E, Franceschi C, Vasto S
A typical feature of ageing is a chronic, low-grade inflammation characterized by a general increase in the production of pro-inflammatory cytokines and inflammatory markers (“inflamm-ageing”). This status may slowly damage one or several organs, especially when unfavorable genetic polymorphisms and epigenetic alterations are concomitant, leading to an increased risk of frailty together with the onset of age-related chronic diseases. The contribution of different tissues (adipose tissue, muscle), organs (brain, liver), immune system and ecosystems (gut microbiota) to age-related inflammation (“inflamm-ageing”) will be discussed in this review in the context of its onset/progression leading to site-restricted and systemic effects. Moreover, some of the possible strategies and therapies to counteract the different sources of molecular mediators which lead to the age-related inflammatory phenotype will be presented.
Purging Cells in Mice Is Found to Combat Aging IllsBy NICHOLAS WADE In a potentially fundamental advance, researchers have opened up a novel approach to combating the effects of aging with the discovery that a special category of cells, known as senescent cells, are bad actors that promote the aging of the tissues. Cleansing the body of the cells, they hope, could postpone many of the diseases of aging. The findings raise the prospect that any therapy that rids the body of senescent cells would protect it from the ravages of aging. But many more tests will be needed before scientists know if drugs can be developed to help people live longer. Senescent cells accumulate in aging tissues, like arthritic knees, cataracts and the plaque that may line elderly arteries. The cells secrete agents that stimulate the immune system and cause low-level inflammation. Until now, there has been no way to tell if the presence of the cells is good, bad or indifferent.